HighTower Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-100
Closed -$945 4047
2024
Q4
$945 Buy
+100
New +$14.9K ﹤0.01% 3707
2016
Q2
Sell
-100
Closed -$680K 2015
2016
Q1
$680K Hold
100
﹤0.01% 1226
2015
Q4
$1K Buy
+100
New +$3.28K ﹤0.01% 2032

Other funds holding THC

HighTower Advisors's THC Position: Q2 2026 in Review

HighTower Advisors reduced its Tenet Healthcare (THC) stake by 24% in Q2 2026, selling an estimated $610K and leaving 10,295 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1804.

HighTower Advisors first reported a position in THC in Q2 2014 and has held it in 27 quarters since. The position peaked at $7.35M in Q2 2015. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • HighTower Advisors held 10,295 shares of Tenet Healthcare worth $1.93M as of Q2 2026.
  • HighTower Advisors sold 3,316 Tenet Healthcare shares in Q2 2026, an estimated $610K.
  • Tenet Healthcare made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1804 holding.
  • HighTower Advisors first reported a position in Tenet Healthcare in Q2 2014 and has held it in 27 quarters since.
  • HighTower Advisors's Tenet Healthcare position peaked at $7.35M in Q2 2015.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.